查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1621574

尿道感染检测市场：按适应症、检测套组、检测项目、最终用户分类 - 全球预测 2025-2030

Urinary Tract Infection Testing Market by Indication (Cystitis, Pyelonephritis, Urethritis), Test Kits (Home Test Kits, Laboratory Test Kits), Tests, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

尿道感染检测市场2023年估值为14亿美元，预计到2024年将达到14.7亿美元，复合年增长率为4.75%，到2030年将达到19.4亿美元。

尿道感染(UTI) 检测市场包括用于识别泌尿器官系统感染疾病（包括膀胱、肾臟、输尿管和尿道）的各种诊断工具和程序。尿道结石检测的必要性源自于疾病的流行，尤其是在女性、老年人和患有糖尿病和脊髓损伤等某些危险因子的人中。应用包括就地检验、家庭检测套组和基于实验室的诊断，重点是细菌鑑定和抗生素敏感性测试。典型的最终用户包括医院、诊断实验室、研究机构和家庭医疗保健环境。市场成长受到尿道结石结石增加、快速检测技术进步以及对非侵入性和准确诊断方法不断增长的需求等因素的影响。我们最新的市场发展包括开发基于人工智慧的诊断工具、将物联网整合到家庭检测套组中，以及扩展到医疗需求未满足的新兴市场。为了利用这些机会，公司应专注于联合研究和合作伙伴关係，以加强其技术并扩大其地理覆盖范围。然而，与先进诊断系统相关的限制，例如高成本以及影响治疗通讯协定的假阴性和假阳性的可能性，为市场成长带来了挑战。监管障碍和临床检验的需求也构成了重大挑战。业务成长的创新领域包括开发具有成本效益的携带式诊断设备、增强微生物培养技术以及扩大病原体的基因识别。儘管市场竞争激烈且分散，但整合远端医疗进行个人化医疗和远距离诊断仍有巨大潜力。对快速生物标记识别和抗药性模式追踪的持续研究至关重要。企业应优先考虑研发投资和策略伙伴关係关係，以推动创新，应对复杂的市场环境，并满足医疗保健提供者和患者不断变化的需求。

主要市场统计
基准年[2023] 14亿美元
预测年份 [2024] 14.7亿美元
预测年份 [2030] 19.4亿美元
复合年增长率（%） 4.75%

市场动态：揭示快速发展的尿道感染感染检测市场的关键市场洞察

供需的动态交互作用正在改变尿道感染检测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球尿道感染增加
    • 抗生素过度使用和抗药性增加导致复杂的尿道感染
  • 市场限制因素
    • 尿道感染检测解决方案产品回想问题
  • 市场机会
    • 不断开发新的影像技术和检测设备
    • 政府积极推动快速诊断普及
  • 市场挑战
    • 与尿道感染相关的社会耻辱

波特五力：驾驭尿道感染感染检测市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解尿道感染检测市场的外部影响

外部宏观环境因素在塑造尿道感染检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解尿道感染检测市场的竞争状况

对尿道感染感染检测市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵尿道感染检测市场供应商绩效评估

FPNV 定位矩阵是评估尿道感染检测市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了尿道感染检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对尿道感染感染检测市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球尿道感染发生率增加
      • 抗生素过度使用和抗药性增加导致复杂的尿道感染
    • 抑制因素
      • 尿道感染检测解决方案产品回想问题
    • 机会
      • 加大新成像技术和检测设备的开发力度
      • 政府为提高快速诊断所采取的有利倡议
    • 任务
      • 关于尿道感染的社会耻辱
  • 市场区隔分析
    • 检测：增加药敏试验的使用以避免处方抗生素
    • 最终用户：在诊断实验室进行尿道感染感染检测以检测细菌是否存在的巨大潜力
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章尿道感染检测市场（依适应症）

  • 膀胱炎
  • 肾盂肾炎
  • 尿道炎
  • 阴道炎

第七章尿道感染检测市场检测试剂套件

  • 家庭检测套组
  • 临床检测套组

第八章尿道感染感染检测市场按检测

  • 药敏试验
  • 尿液检查
  • 尿液培养

第九章尿道感染感染检测市场：依最终用户分类

  • 诊断实验室
  • 医院
  • 肾臟病门诊

第十章美洲尿道感染检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太尿道感染检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲尿道感染检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • PathogenDx 用于尿道感染检测的生态高效 D3 阵列平台方法
    • Vivoo推出智慧家庭测试解决方案，推进泌尿道感染诊断
    • 由德州大学德克萨斯分校的研究人员开发的新型诊断感测器
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Accelerate Diagnostics, Inc.
  • ACON Laboratories, Inc.
  • Beckman Coulter, Inc. by Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Cardinal Health Inc.
  • Chungdo Pharm Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Genetworx, LLC
  • Module Innovations Pvt. Ltd.
  • Piramal Pharma Limited
  • QIAGEN GmbH
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • Stryker Corporation
  • SYSMEX CORPORATION
  • T2 Biosystems, Inc.
  • Thermo Fisher Scientific Inc.
  • Vivosens Inc.
Product Code: MRR-7C50F27396DF

The Urinary Tract Infection Testing Market was valued at USD 1.40 billion in 2023, expected to reach USD 1.47 billion in 2024, and is projected to grow at a CAGR of 4.75%, to USD 1.94 billion by 2030.

The urinary tract infection (UTI) testing market encompasses various diagnostic tools and procedures used to identify infections in the urinary system, including the bladder, kidneys, ureters, and urethra. The necessity for UTI testing is driven by the prevalence of the condition, particularly among women, the elderly, and those with certain risk factors such as diabetes or spinal cord injuries. Applications include point-of-care testing, home testing kits, and laboratory-based diagnostics, with a focus on bacteria identification and antibiotic susceptibility testing. Key end-users include hospitals, diagnostic laboratories, research institutes, and home healthcare settings. Market growth is influenced by factors such as increasing UTI incidences, advancements in rapid testing technologies, and a growing demand for non-invasive and accurate diagnostic methods. Latest opportunities include the development of AI-based diagnostic tools, integration of IoT in home testing kits, and expansion in emerging markets with high unmet medical needs. Companies should focus on collaborations and partnerships for technology enhancement and geographic expansion to leverage these opportunities. However, market growth is challenged by limitations such as high costs associated with advanced diagnostic systems and the potential for false-negative or false-positive outcomes, which can affect treatment protocols. Regulatory hurdles and the need for clinical validation also pose significant challenges. For business growth, areas of innovation include developing cost-effective and portable diagnostic devices, enhancing microbial culture techniques, and expanding the genetic identification of pathogens. The market is competitive and fragmented, with significant potential in personalized medicine and the integration of telemedicine for remote diagnosis. Continued research into rapid biomarker identification and resistance pattern tracking will be pivotal. Businesses should prioritize investment in R&D and strategic partnerships to navigate this complex market landscape, fostering innovations that meet the evolving needs of healthcare providers and patients alike.

KEY MARKET STATISTICS
Base Year [2023] USD 1.40 billion
Estimated Year [2024] USD 1.47 billion
Forecast Year [2030] USD 1.94 billion
CAGR (%) 4.75%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Urinary Tract Infection Testing Market

The Urinary Tract Infection Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of urinary tract infections worldwide
    • Complicated UTIs due to a rise in excessive use of antibiotics and drug resistance
  • Market Restraints
    • Product recall issues with the urinary tract infection testing solutions
  • Market Opportunities
    • Rising development of new imaging technologies and testing devices
    • Favorable initiatives by the government to increase rapid diagnostics
  • Market Challenges
    • Social stigma concerning urinary tract infections

Porter's Five Forces: A Strategic Tool for Navigating the Urinary Tract Infection Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Urinary Tract Infection Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Urinary Tract Infection Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Urinary Tract Infection Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Urinary Tract Infection Testing Market

A detailed market share analysis in the Urinary Tract Infection Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Urinary Tract Infection Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Urinary Tract Infection Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Urinary Tract Infection Testing Market

A strategic analysis of the Urinary Tract Infection Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Urinary Tract Infection Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., ACON Laboratories, Inc., Beckman Coulter, Inc. by Danaher Corporation, Bio-Rad Laboratories, Inc., bioMerieux SA, Cardinal Health Inc., Chungdo Pharm Co., Ltd., F. Hoffmann-La Roche Ltd., Genetworx, LLC, Module Innovations Pvt. Ltd., Piramal Pharma Limited, QIAGEN GmbH, Randox Laboratories Ltd., Siemens Healthineers, Stryker Corporation, SYSMEX CORPORATION, T2 Biosystems, Inc., Thermo Fisher Scientific Inc., and Vivosens Inc..

Market Segmentation & Coverage

This research report categorizes the Urinary Tract Infection Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Cystitis, Pyelonephritis, Urethritis, and Vaginitis.
  • Based on Test Kits, market is studied across Home Test Kits and Laboratory Test Kits.
  • Based on Tests, market is studied across Susceptibility Testing, Urinalysis, and Urine Cultures.
  • Based on End User, market is studied across Diagnostic Laboratories, Hospitals, and Nephropathy Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of urinary tract infections worldwide
      • 5.1.1.2. Complicated UTIs due to a rise in excessive use of antibiotics and drug resistance
    • 5.1.2. Restraints
      • 5.1.2.1. Product recall issues with the urinary tract infection testing solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising development of new imaging technologies and testing devices
      • 5.1.3.2. Favorable initiatives by the government to increase rapid diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Social stigma concerning urinary tract infections
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Tests: Rising usage of susceptibility testing to avoid prescribing antibiotics
    • 5.2.2. End User: High potential for urinary tract infection testing in diagnostic laboratories to detect the presence of bacteria
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Urinary Tract Infection Testing Market, by Indication

  • 6.1. Introduction
  • 6.2. Cystitis
  • 6.3. Pyelonephritis
  • 6.4. Urethritis
  • 6.5. Vaginitis

7. Urinary Tract Infection Testing Market, by Test Kits

  • 7.1. Introduction
  • 7.2. Home Test Kits
  • 7.3. Laboratory Test Kits

8. Urinary Tract Infection Testing Market, by Tests

  • 8.1. Introduction
  • 8.2. Susceptibility Testing
  • 8.3. Urinalysis
  • 8.4. Urine Cultures

9. Urinary Tract Infection Testing Market, by End User

  • 9.1. Introduction
  • 9.2. Diagnostic Laboratories
  • 9.3. Hospitals
  • 9.4. Nephropathy Clinics

10. Americas Urinary Tract Infection Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Urinary Tract Infection Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Urinary Tract Infection Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. PathogenDx's Eco-efficient D3 Array Platform Approach for Urinary Tract Infection Testing
    • 13.3.2. Vivoo Unveils Smart At-Home Testing Solution Advancing UTI Diagnostics
    • 13.3.3. A Novel Diagnostic Sensor Developed by University of Texas at Dallas Researchers
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Accelerate Diagnostics, Inc.
  • 3. ACON Laboratories, Inc.
  • 4. Beckman Coulter, Inc. by Danaher Corporation
  • 5. Bio-Rad Laboratories, Inc.
  • 6. bioMerieux SA
  • 7. Cardinal Health Inc.
  • 8. Chungdo Pharm Co., Ltd.
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. Genetworx, LLC
  • 11. Module Innovations Pvt. Ltd.
  • 12. Piramal Pharma Limited
  • 13. QIAGEN GmbH
  • 14. Randox Laboratories Ltd.
  • 15. Siemens Healthineers
  • 16. Stryker Corporation
  • 17. SYSMEX CORPORATION
  • 18. T2 Biosystems, Inc.
  • 19. Thermo Fisher Scientific Inc.
  • 20. Vivosens Inc.

LIST OF FIGURES

  • FIGURE 1. URINARY TRACT INFECTION TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. URINARY TRACT INFECTION TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. URINARY TRACT INFECTION TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. URINARY TRACT INFECTION TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CYSTITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URETHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY VAGINITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOME TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY LABORATORY TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUSCEPTIBILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINE CULTURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEPHROPATHY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2023